1. Disease Overview

Atrial septal defect (ASD) is a congenital heart defect—an abnormal opening in the atrial septum, the wall dividing the heart’s two upper chambers (atria). Because pressure is higher on the left, oxygenated blood shunts back into the right atrium (a left-to-right shunt), sending extra blood to the lungs and overloading the right heart. ASDs make up roughly 10–15% of congenital heart disease. Small defects often close on their own in infancy, but moderate-to-large ones gradually enlarge the right atrium and ventricle and, if untreated for decades, can cause arrhythmias, pulmonary hypertension, right heart failure, or stroke from a clot crossing the defect. Reassuringly, ASD is highly treatable: with minimally invasive device closure or surgical repair, most children and adults return to completely normal lives with a normal life expectancy.

2. Key Facts at a Glance

Aspect	Details
Also known as	Atrial septal defect, ASD, “hole in the heart,” interatrial communication
Body system affected	Cardiovascular system (heart, specifically the atrial septum)
Common in	Congenital (present at birth); diagnosed in childhood or adulthood
Severity range	Small (may close on its own) to large (requires intervention)
Key treatments	Watchful waiting, transcatheter device closure, surgical repair
Outlook	Excellent with timely treatment; normal life expectancy after repair

3. Alternative Names and Medical Terminology

Common names include atrial septal defect (ASD), the lay term “hole in the heart,” and the formal interatrial communication. The main types are secundum (central septum), primum (lower septum), sinus venosus (near the vena cava), and rare coronary sinus ASD. Related terms are left-to-right shunt, right heart volume overload, and pulmonary overcirculation.

4. Relevant Heart, Lung or Vascular Anatomy

The atrial septum separates the left and right atria and is normally solid after birth. In fetal life the foramen ovale lets blood bypass the non-working lungs; rising left atrial pressure normally seals it after birth, though a flap-like patent foramen ovale (PFO) persists in about a quarter of adults and is usually harmless. Nearby structures include the vena cavae and pulmonary veins returning blood to the atria, and the tricuspid and mitral valves. Where a defect sits within this anatomy defines its type and whether device or surgical closure is needed.

5. How the Disease Affects the Body

An ASD alters blood flow rather than the heart’s rhythm or muscle directly. Because the left atrium is a higher-pressure chamber, oxygenated blood crosses the defect into the right atrium—a left-to-right shunt—so the right atrium, right ventricle, and lungs handle excess volume with every beat. Over time this volume overload produces progressive right heart enlargement and chronic pulmonary overcirculation, though many patients stay symptom-free for years. When a significant shunt persists untreated, consequences accumulate: the stretched atrium becomes prone to atrial fibrillation and flutter; the right ventricle can weaken, causing right heart failure; high pulmonary flow may raise pressures (pulmonary hypertension); and a venous clot can cross into the systemic circulation (paradoxical embolism), risking stroke. In advanced cases the shunt reverses to right-to-left, causing cyanosis (Eisenmenger syndrome). Timely closure interrupts this cascade before permanent damage develops.

6. Types and Classification

By location: secundum (70–80%), central septum, usually device-suitable; primum (15–20%), near the AV valves, often with a cleft mitral valve, needs surgery; sinus venosus (5–10%), near the vena cava, often with anomalous pulmonary venous drainage, needs surgery; coronary sinus (<1%), rare, surgical. By size: small (<5 mm), moderate (5–10 mm), large (>10 mm). By significance: a Qp:Qs (pulmonary-to-systemic flow) ratio above 1.5:1 defines a significant shunt.

7. Causes of the Disease

ASD is congenital, arising during fetal formation of the atrial septum from combined genetic and environmental factors—excessive resorption or incomplete formation of septal tissue, or failure of the foramen ovale to close. Contributors include chromosomal abnormalities (notably trisomy 21), single-gene syndromes (e.g., Holt-Oram), and maternal factors such as poorly controlled diabetes, alcohol, smoking, rubella, and certain medications. ASD cannot be acquired later in life, and in most cases no specific cause is found.

8. How the Disease Develops

The atrial septum forms early in pregnancy: the septum primum grows down from the atrial roof and the septum secundum forms alongside it, leaving the foramen ovale as a flap valve that lets oxygen-rich placental blood bypass the fluid-filled lungs. At birth the lungs expand and left atrial pressure rises, pressing the two septa together to seal the opening. An ASD develops when this fails—excessive resorption, incomplete formation, an oversized foramen ovale, or non-fusion of the septa. After birth the defect allows continuous left-to-right shunting, which causes few early symptoms while the right heart enlarges silently over months to years—so many moderate ASDs are diagnosed only in adulthood.

9. Risk Factors

Most risk factors act on the fetus during pregnancy; ASD cannot develop after birth. They include a family history of CHD (recurrence roughly 2–5%); maternal diabetes, obesity, phenylketonuria, or rubella; exposures to alcohol, tobacco, certain medications, recreational drugs, or industrial chemicals; and fetal chromosomal abnormalities (trisomy 21 highest) or multiple gestation. In most children, no specific risk factor is identified.

10. Genetic and Family-History Factors

Most isolated ASDs are sporadic and multifactorial, with no single causative gene. A family history modestly raises recurrence risk—about 2–3% with an affected sibling and 2–5% with an affected parent, versus under 1% generally. ASD is common in Down, Edwards, Patau, and Turner syndromes and single-gene disorders such as Holt-Oram (TBX5), GATA4, and NKX2-5. Routine genetic testing is not needed for isolated ASD, but microarray or targeted panels—with counseling—suit dysmorphic features, developmental delay, other anomalies, or a strong family history.

11. Who Is Most at Risk?

ASD occurs in all ethnic groups worldwide with a notable female predominance (about 2:1). Because it forms before birth, the highest-risk factors relate to pregnancy: maternal pre-gestational diabetes, obesity, advanced or very young maternal age, alcohol or tobacco use, teratogenic medications, and fetal chromosomal abnormalities (especially trisomy 21), with a family history of CHD adding a smaller increment.

12. Prevalence and Epidemiology

CHD affects roughly 1% of live births, and ASD accounts for about 10–15% of cases. Roughly half of ASDs are diagnosed in childhood and half in adulthood, with a clear female predominance (around 65–70%). A PFO—present in 25–30% of adults—is a distinct, usually insignificant finding not to be confused with a true ASD.

13. Signs and Symptoms

Presentation varies with size. Small ASDs are usually asymptomatic and found incidentally. Moderate-to-large defects may cause, in children, frequent respiratory infections, reduced exercise tolerance, and fatigue; and in adults, exercise intolerance, exertional breathlessness, palpitations, atrial arrhythmias, and eventually right heart failure with leg swelling. The characteristic sign is a fixed, widely split second heart sound (S2)—the hallmark of ASD—with a soft systolic pulmonary flow murmur; many adults stay symptom-free until arrhythmias or heart failure appear, sometimes decades later.

14. Early-Stage Symptoms

In infancy and early childhood, ASD is often silent even when moderate; most children grow, feed, and develop normally. Subtle early clues, when present, include tiring more easily than peers, more frequent chest infections, and mild breathlessness with vigorous play. The defect is frequently first suspected when a murmur or fixed split S2 is heard on a routine or sports physical.

15. Advanced-Stage Symptoms

Advanced symptoms occur mainly in middle-aged or older adults with large, long-untreated defects—now uncommon with modern care. They reflect years of right heart overload: right heart failure (breathlessness, leg swelling, enlarged liver, distended neck veins, ascites); arrhythmias (atrial fibrillation or flutter, occasionally fainting); recurrent chest infections; paradoxical embolism (stroke or TIA); and, late, Eisenmenger syndrome with cyanosis and finger clubbing.

16. Symptoms in Women, Men and Older Adults

ASD is more common in women (about two-thirds of cases), who face specific pregnancy considerations, though the symptom pattern is broadly similar between the sexes. In older adults, presentation is often atypical—a new atrial arrhythmia, unexplained breathlessness, reduced stamina dismissed as “aging,” or a stroke may be the first clue, and coexisting coronary or valve disease can mask the diagnosis.

17. Emergency Warning Signs

Serious emergencies are uncommon but need immediate care. Call emergency services (911/112) for stroke symptoms (FAST: face drooping, arm weakness, speech difficulty)—possible paradoxical embolism; fainting, especially with exertion; sustained rapid palpitations with chest discomfort or severe breathlessness; or sudden severe shortness of breath.

18. When to Seek Medical Help

Seek prompt (days to weeks) review for new or worsening breathlessness, declining exercise tolerance, palpitations, new leg or abdominal swelling, or limiting fatigue. Arrange routine review after an incidental ASD or murmur is found, for pre-conception counseling, or before non-cardiac surgery. Seek emergency care for stroke symptoms, syncope, sudden severe dyspnea, or chest pain with other cardiac symptoms.

19. Disease Stages, Grades and Severity

Severity is judged mainly by size and shunt magnitude: small (<5 mm, usually insignificant, may close on its own), moderate (5–10 mm, close if right heart enlargement develops), and large (>10 mm, closure generally advised). Qp:Qs below 1.5:1 is small, 1.5–2.0:1 moderate, and above 2.0:1 large. The key marker of significance is right heart enlargement. Any pulmonary hypertension warrants urgent, specialized assessment to determine whether closure is still appropriate.

20. Disease Progression

Moderate-to-large defects follow a slow course: childhood is usually asymptomatic; the 20s–30s may bring reduced stamina, fatigue, early arrhythmias, and measurable right heart enlargement; by the 40s–50s, breathlessness, atrial fibrillation, and early right heart failure become more common, with pulmonary hypertension beginning. Untreated older adults can develop established right heart failure, severe pulmonary hypertension, and Eisenmenger syndrome, whereas timely closure allows the right heart to remodel toward normal over 12–24 months.

21. Possible Complications

Untreated significant ASD can cause right heart problems (progressive dilation, right ventricular hypertrophy, right heart failure, secondary tricuspid regurgitation); pulmonary complications (pulmonary hypertension, pulmonary vascular disease, recurrent infections); arrhythmias (atrial fibrillation and flutter increasing with age, sick sinus syndrome, and heart block with primum defects); neurological events (paradoxical stroke or TIA); and, late, Eisenmenger syndrome. Rare procedural complications include device embolization or erosion and surgical bleeding, infection, or residual defect. Most are preventable with timely closure.

ASD may coexist with other congenital defects—mitral valve prolapse or regurgitation (especially the cleft valve of primum ASD), tricuspid regurgitation, pulmonary stenosis, VSD, or PDA—and with syndromes such as Down and Holt-Oram. Secondary and acquired conditions include atrial fibrillation/flutter, pulmonary hypertension, stroke from paradoxical embolism, and, in older patients, coronary artery disease, hypertension, and degenerative valve disease.

23. Screening and Early Detection

Prenatally, the second-trimester anomaly scan (18–22 weeks) and fetal echocardiography can detect major CHD, though many ASDs are missed. After birth, newborn examination and pulse oximetry screen for critical CHD (less sensitive for ASD), and routine well-child and sports physicals may detect a murmur or fixed split S2. There is no routine adult screening; evaluation is triggered by symptoms, incidental imaging, a family history of CHD, or an unexplained stroke/TIA. Echocardiography is the primary screening tool—noninvasive and highly sensitive.

24. How the Disease Is Diagnosed

Diagnosis begins with a history and examination (the fixed split S2 and a pulmonary flow murmur) and an ECG (which may show right axis deviation or right bundle branch block). The cornerstone test is transthoracic echocardiography (TTE), which shows the defect’s size and location, the shunt’s direction and magnitude, right heart size and function, and associated anomalies. When more detail is needed—especially for sinus venosus defects or to plan device closure—transesophageal echocardiography (TEE) gives superior septal views, while cardiac MRI or CT quantify the shunt and define complex anatomy. Cardiac catheterization measures pulmonary vascular resistance when pulmonary hypertension is suspected.

25. Physical Examination and Medical History

The history focuses on exercise tolerance, breathlessness, fatigue, palpitations, syncope, and neurological events, plus developmental and family history. On examination, oxygen saturation is usually normal (unless Eisenmenger syndrome is present); palpation may reveal a right ventricular heave; and the auscultatory hallmark is a fixed, widely split S2 with a soft systolic pulmonary murmur. Large shunts add a tricuspid rumble, and right heart failure brings hepatomegaly, raised neck veins, and edema, though the examination is frequently normal in small ASDs.

26. Diagnostic Tests and Imaging

Transthoracic echocardiography (TTE): first-line; shows the defect, shunt, size, location, right heart size, and associated anomalies.
Transesophageal echocardiography (TEE): superior septal detail; assesses rims and guides device closure; best for sinus venosus defects.
Cardiac MRI / CT: precise anatomy, Qp:Qs quantification, right ventricular volumes, and anomalous venous drainage.
ECG: right axis deviation, right bundle branch block, or atrial arrhythmias.
Chest X-ray: increased pulmonary markings and prominent right heart (often normal in small defects).
Cardiac catheterization: gold-standard shunt and pulmonary resistance measurement.

27. Blood Tests, Biomarkers and Genetic Testing

ASD has no diagnostic blood test; laboratory work is mainly for procedural safety and complications. Pre-procedure testing typically includes a complete blood count, coagulation studies, and a basic metabolic panel (kidney function is relevant to contrast use). BNP/NT-proBNP helps assess right heart failure, a thrombophilia workup may follow a paradoxical embolism, and genetic testing—karyotype, microarray, or targeted panels with counseling—is reserved for syndromic features, developmental delay, other anomalies, or a strong family history.

28. Understanding Test Results

Echocardiography reports the defect’s size (small <5 mm, moderate 5–10 mm, large >10 mm), location, the rims available for a device, and the shunt direction and Qp:Qs (>1.5:1 significant, >2.0:1 large). The most important consequence is right heart enlargement, which signals a significant shunt and supports closure. ECG may show right axis deviation, an rSR′ pattern, or atrial arrhythmias, and catheterization gives exact Qp:Qs and pulmonary resistance to judge operability.

29. Differential Diagnosis

Conditions that mimic ASD include other left-to-right shunts—ventricular septal defect (harsh holosystolic murmur), patent ductus arteriosus (continuous “machinery” murmur), and partial anomalous pulmonary venous return (often with sinus venosus ASD). Non-shunt causes of right heart enlargement include primary tricuspid regurgitation and pulmonary hypertension from lung disease, while an atrial septal aneurysm shows a mobile septum without a true defect. In stroke work-up, distinguishing a PFO from a true ASD matters because treatment differs. Echocardiography, MRI, or CT reliably separates these.

30. Specialist and Multidisciplinary Evaluation

ASD care is team-based. A pediatric cardiologist or, for adults, an adult congenital heart disease (ACHD) specialist leads diagnosis and planning. An interventional cardiologist performs device closure, while a cardiac surgeon handles defects unsuitable for a device (primum, sinus venosus, very large, or with associated anomalies). An electrophysiologist manages arrhythmias and a heart failure specialist assists with advanced right heart failure. Complex cases go to the heart team for a consensus recommendation.

31. Treatment Goals

The aims are to eliminate the shunt and thereby prevent complications—right heart failure, pulmonary hypertension, atrial arrhythmias, paradoxical embolism, and Eisenmenger syndrome. Closing the defect normalizes hemodynamics, lets the right heart remodel, and restores exercise capacity, usually as a single, essentially curative intervention with normal life expectancy—ideally before complications develop, and with special attention to women planning pregnancy.

32. When Is Treatment Required?

Closure is indicated for a significant shunt (Qp:Qs >1.5:1), right heart enlargement, symptoms, ASD-related arrhythmias, right heart failure, or paradoxical embolism—and for still-operable pulmonary hypertension confirmed by catheterization. It is also considered for moderate defects with progressive enlargement and before a planned pregnancy. Observation suits very small defects (<5 mm) without shunt or enlargement, while closure is contraindicated once irreversible pulmonary hypertension/Eisenmenger syndrome has developed.

33. Active Monitoring and Watchful Waiting

Observation suits small ASDs (<5 mm) with no right heart enlargement, no symptoms, and normal pulmonary pressures. Monitoring centers on serial echocardiography—every 6–12 months in infants (extending if stable), roughly annually in children, and every 1–2 years in adults—plus periodic ECGs for arrhythmias. No medication is needed, and normal activity is encouraged. Closure is discussed if symptoms, right heart enlargement, or arrhythmias develop, before a planned pregnancy, or after a paradoxical embolic event.

34. Medications

No drug closes an ASD—device or surgical closure is definitive. Medications treat complications or are used around procedures: for right heart failure, diuretics, ACE inhibitors/ARBs, aldosterone antagonists, and beta-blockers; for arrhythmias, rate- or rhythm-control agents plus anticoagulation if atrial fibrillation is present; for pulmonary hypertension, endothelin receptor antagonists, PDE-5 inhibitors, riociguat, or prostacyclin analogs. Peri-procedurally, prophylactic antibiotics, and after device closure, aspirin for about 6 months.

35. Minimally Invasive Treatments

Transcatheter device closure is the minimally invasive standard for suitable defects. A catheter passed through a femoral vein delivers a self-expanding double-disc occluder (such as the Amplatzer or Gore devices—a nitinol frame with fabric patches) across the defect, sealing it immediately; tissue grows over it over 3–6 months. Ideal candidates have a secundum ASD of appropriate size with adequate rims and no anomalies needing surgery. Advantages include no chest incision or bypass, a short (often overnight) stay, recovery within days, success above 95%, and minimal scarring. It is not suitable for primum or sinus venosus defects, very large defects, or those with inadequate rims.

36. Catheter-Based and Endovascular Treatments

Before device closure, TEE (sometimes MRI/CT) precisely measures the defect and rims, and catheterization assesses hemodynamics if pulmonary hypertension is suspected. Under sedation, using femoral vein access, the delivery sheath crosses the defect, the left disc opens in the left atrium, the sheath is withdrawn so the device straddles the septum, and the right disc opens in the right atrium, with position confirmed by imaging before release. Afterward, patients take aspirin for about 6 months and have echocardiograms at 1 month, 6 months, and 1 year. Technical success exceeds 95%, complete closure exceeds 90% by 6–12 months, small residual shunts occur in 5–10%, and serious complications are under 5%.

37. Surgical Treatment Options

Surgery is required when a device is unsuitable—primum, sinus venosus, and coronary sinus defects, very large secundum defects with inadequate rims, associated anomalies, or a failed device. The standard approach is a median sternotomy on cardiopulmonary bypass: the heart is arrested, the right atrium opened, and the defect repaired by direct suture (small defects) or a patch of the patient’s own pericardium or synthetic material (larger defects). Minimally invasive approaches achieve the same repair with better cosmesis in selected patients, and surgery also allows concomitant procedures—mitral valve repair for a cleft valve, tricuspid annuloplasty, rerouting of anomalous veins, or a maze procedure. Recovery includes about a day in intensive care, a 3–5 day stay, and 6–8 weeks to full activity while the sternum heals. Outcomes are excellent: closure success above 98%, elective mortality under 1%, and durable repair for every ASD type.

38. Advanced and Emerging Treatments

Innovation continues on several fronts. Novel devices—bioresorbable occluders that dissolve after healing and lower-profile devices for smaller children—are in development. Minimally invasive, robotic, and thoracoscopic surgery reduces incision size in selected patients. Advanced guidance, including 3D printing for planning and intracardiac echocardiography (ICE) (which can replace TEE and general anesthesia during device closure), is expanding. More experimental directions—fetal intervention, tissue engineering, and stem-cell repair—remain research-stage.

39. Treatment Options Compared

Treatment	Best For	Advantages	Disadvantages	Recovery
Observation	Small ASDs, no shunt or symptoms	No procedure or risk	Ongoing monitoring; late-complication risk	None
Device closure	Secundum ASD, adequate rims	Minimally invasive, short stay, small scar, >95% success	Not for all types; small device risks; permanent implant	Days to weeks
Surgical closure	Primum, sinus venosus, large, or associated anomalies	Definitive; repairs associated defects; no implant	Invasive; bypass; chest scar	6–8 weeks
Minimally invasive surgery	Selected defects, expert centers	Smaller incisions, cosmetic benefit	Technically demanding, limited availability	4–6 weeks
Medical therapy	Complications before closure	Manages symptoms; bridges to treatment	Does not close the defect	Varies

The choice hinges on defect type, size, rims, associated anomalies, and patient preference.

40. How Doctors Choose the Right Treatment

After comprehensive assessment of the defect, shunt, right heart size, symptoms, and comorbidities, doctors decide whether closure is indicated—generally yes for Qp:Qs >1.5:1, right heart enlargement, symptoms, or complications—and choose the method: a device for a suitable secundum defect, or surgery for primum/sinus venosus/coronary sinus defects, inadequate rims, oversized defects, or lesions needing concurrent repair. Timing is elective before complications but urgent after paradoxical embolism, and complex cases are decided by the heart team.

41. Benefits and Risks of Treatment

Benefits of closure are substantial: eliminating the shunt prevents right heart failure, pulmonary hypertension, arrhythmias, and paradoxical embolism, relieves symptoms, and usually provides a one-time cure. Risks of device closure (about 3–5%) include device embolization, pericardial effusion, vascular injury, transient arrhythmias, and rare late erosion or thrombosis; a small residual shunt occurs in 5–10%. Risks of surgery (about 5–10%) include bleeding, infection, stroke (<1%), transient arrhythmias, and elective mortality under 1%. For well-selected patients, benefits clearly outweigh these low risks.

42. What Happens If the Disease Is Left Untreated?

The natural history is gradual. Through the 20s–40s, breathlessness, fatigue, and atrial arrhythmias may appear, and after age 40–60, right heart failure, atrial fibrillation, and pulmonary hypertension become more likely, with an ongoing risk of paradoxical stroke. In later life, large defects can progress to severe, often irreversible pulmonary hypertension, culminating in Eisenmenger syndrome—shunt reversal, cyanosis, and a 5-year survival often below 50%, at which point closure no longer helps. Closing the defect before right heart failure or pulmonary hypertension develops prevents nearly all of these outcomes.

43. Treatment Success and Expected Outcomes

Device closure achieves technical success above 95% and complete closure over 90% by 6–12 months, with complications under 5%; surgical closure achieves success above 98% with durable repair for all defect types. After closure, most patients report resolved breathlessness, normalized exercise tolerance, and reversal of right heart failure. The right heart remodels—the right atrium normalizes within 6–12 months and the right ventricle over 12–24 months. Arrhythmia risk falls, though pre-existing atrial fibrillation may persist, and reintervention is needed in under 5%.

44. Prognosis and Long-Term Outlook

The outlook after ASD closure is excellent, with normal life expectancy and quality of life when the defect is closed before complications develop. After device closure, 10-year survival exceeds 95% with freedom from reintervention above 90%; after surgery, 20-year survival for isolated ASD exceeds 90%. Prognosis depends heavily on timing: closure in childhood or young adulthood virtually eliminates late complications, while in older adults the outlook depends on pre-existing damage. Favorable factors include early, complete closure, normal right ventricular function, and sinus rhythm; adverse factors include late closure, irreversible pulmonary hypertension, and persistent atrial fibrillation.

45. Recovery and Rehabilitation

After device closure, patients are monitored overnight, have a confirmatory echocardiogram, and usually go home the next day. Heavy lifting is avoided for 1–2 weeks, sedentary work resumes within days, and full activity—including competitive sport—returns within 3–6 months, with aspirin continued for about 6 months. After surgery, recovery is longer: about a day in intensive care and a 3–5 day stay; at home, patients avoid lifting over 10 lb and driving for about 4–6 weeks while the sternum heals, returning to full activity over 3–6 months, often aided by cardiac rehabilitation.

46. Follow-Up Tests and Long-Term Monitoring

After device closure, follow-up includes echocardiography and ECG at 1 month, 6 months, and 1 year, then periodic checks for residual shunt, device position, and right heart remodeling; aspirin is usually stopped at 6 months. After surgery, an early wound check is followed by echocardiograms and ECGs at roughly 6–8 weeks, 6 months, and 1 year. Lifelong monitoring focuses on right heart size, atrial arrhythmias, and functional status; endocarditis prophylaxis is not required except for the first 6 months after device placement or with a residual defect. Report promptly any new breathlessness, palpitations, syncope, or leg swelling.

47. Managing Recurrence or Disease Progression

True recurrence is uncommon. Small residual shunts occur in 5–10% after device closure and under 5% after surgery; most are insignificant and simply monitored, but a significant residual defect can be closed again. If closure is delayed, the right heart continues to enlarge and arrhythmias or pulmonary hypertension may develop. Device complications such as embolization or rare erosion require retrieval or surgery. Late atrial arrhythmias are managed with rate/rhythm control, anticoagulation, ablation, or a pacemaker if sick sinus syndrome develops, and pulmonary hypertension present before closure may persist and need specific therapy.

48. Living with the Disease

Before closure, most people with small ASDs have no symptoms, need no medication, and live entirely normal lives with periodic monitoring; larger unrepaired defects may cause symptoms and warrant eventual closure. After closure, patients return to fully normal life once recovered—unrestricted work, exercise, competitive sport, travel, and driving—and most need no long-term medication (aside from aspirin for 6 months after a device). Long-term quality of life and life expectancy are essentially normal.

49. Diet and Nutrition Guidelines

ASD requires no special diet, but a heart-healthy eating pattern—such as the Mediterranean or DASH diet—supports cardiovascular health before and after closure. Practical targets: limit saturated fat, avoid trans fat, keep sodium under 2,300 mg/day (lower if hypertensive or in heart failure), emphasize fiber and omega-3s, and moderate alcohol and added sugars. If right heart failure is present, tighter sodium and fluid restriction with daily weight checks helps control retention.

50. Exercise and Physical-Activity Guidelines

Before closure, most people with small ASDs need no restriction, including competitive sport; stop and seek review for chest pain, severe breathlessness, or dizziness. After device closure, heavy lifting is avoided for 1–2 weeks and full exercise and sport resume within weeks to 3 months; after surgery, activity builds gradually with no heavy lifting for 6–8 weeks and full sport by around 6 months. Long term, aim for about 150 minutes/week of moderate aerobic activity plus twice-weekly strength training, with cardiac rehabilitation valuable after surgery.

51. Medications, Activities and Habits to Avoid

Medications: use NSAIDs cautiously (prefer acetaminophen), especially with pulmonary hypertension or right heart failure; use decongestants and stimulant weight-loss agents carefully; and tell your cardiologist about all herbal supplements.
Habits: do not smoke, limit alcohol, and never use recreational stimulants such as cocaine.
During recovery: avoid heavy lifting and strenuous or contact sport until cleared (about 1–3 months after a device; up to 3 months after surgery).
Special activities: get medical clearance before scuba diving and high-altitude travel.
Endocarditis prophylaxis is not needed for isolated ASD, except for the first 6 months after device closure, with a residual defect, or after prior endocarditis.

52. Preventing the Disease or Reducing Its Risks

Most ASDs cannot be prevented because they form during fetal development, but some risk can be reduced through a healthy pregnancy: pre-conception optimization of diabetes, hypertension, and weight; folic acid supplementation; rubella immunity; and avoidance of alcohol, tobacco, illicit drugs, teratogenic medications, and chemical exposures. Genetic counseling helps families with prior CHD. For people who already have an ASD, the focus shifts to preventing complications through regular monitoring, timely closure, and a heart-healthy lifestyle.

53. Pregnancy and the Disease

Pregnancy adds substantial cardiovascular load. Women with small unrepaired ASDs usually tolerate it well with standard care. Moderate-to-large unrepaired defects raise the risk of arrhythmias, right heart failure, and paradoxical embolism, so closure before pregnancy is ideal; pregnancy is contraindicated with Eisenmenger syndrome because of very high maternal mortality. After successful closure, pregnancy is generally low-risk with a safe vaginal delivery. Management includes pre-conception counseling (including a 2–5% recurrence risk for the baby) and multidisciplinary care; beta-blockers and digoxin are generally safe, whereas ACE inhibitors/ARBs and warfarin are avoided.

54. Disease in Children and Young Adults

Most children with ASD are asymptomatic and grow normally; the defect is often found incidentally or via a murmur, with occasional chest infections, reduced stamina, or—rarely—poor growth. Small defects may close spontaneously in the first few years, while symptoms and early arrhythmias more often appear in adolescence or young adulthood. Most activities and competitive sport are allowed even before closure. Timing of closure is individualized: significant defects are typically closed before school age, and any symptomatic defect regardless of age. In late adolescence, care should transition to an adult congenital heart specialist.

55. Disease in Older Adults

In adults over 60, ASD is often discovered when an atrial arrhythmia, unexplained breathlessness, right heart failure, or stroke brings the patient to attention—symptoms easily misattributed to aging or coexisting disease. Long-standing shunts make pulmonary hypertension and arrhythmias more likely, so catheterization to assess reversibility is important before closure. Closure remains beneficial even at older ages, improving symptoms and allowing some right heart remodeling, and device closure is generally preferred for its lower risk. Decisions weigh comorbidities, frailty, and patient goals—age alone is not a contraindication.

56. Emotional Health and Patient Support

A cardiac diagnosis commonly triggers anxiety, fear, and—among parents—guilt, followed by procedural anxiety and usually relief after treatment. Depression and health anxiety are somewhat more common in chronic cardiac conditions and are very treatable. Support resources include psychologists or psychiatrists, social workers, child-life specialists, genetic counselors, and CHD peer-support groups. Helpful coping strategies include education, active participation in decisions, and stress-management techniques such as mindfulness and cognitive behavioral therapy.

57. Preparing for Your Specialist Appointment

Prepare by gathering medical records (prior echocardiograms, ECGs, catheterization or operative reports), a complete medication and allergy list, and a symptom diary noting exercise tolerance, breathlessness, fatigue, and palpitations. Write down your questions in priority order and bring someone to help take notes. During the visit, describe symptoms specifically (e.g., “breathless after two flights of stairs”). Before leaving, confirm the follow-up plan: further tests, next appointment, medications, activity guidance, and when to seek emergency care.

58. Questions to Ask Your Doctor

What type and size of ASD do I have, and what is my shunt ratio (Qp:Qs)?
Is my right heart enlarged, and is that reversible with treatment?
Are there any associated heart problems I should know about?
Do I need treatment now, or can we safely watch and wait? What are the risks of waiting?
Am I a candidate for device closure, or is surgery recommended—and why?
What are the risks of the recommended procedure, and how many have you performed with what outcomes?
What will recovery be like, and when can I return to work, driving, and sport?
What medications and follow-up tests will I need, and for how long?
Will this affect pregnancy, my life expectancy, or my children’s risk of an ASD?
When should I seek emergency care, and do you recommend a second opinion?

59. Cost of Diagnosis and Treatment

Service	United States	India	Turkey	Thailand	Singapore
Cardiology consultation	$200–500	$50–150	$80–200	$100–250	$200–400
Transthoracic echocardiogram	$500–2,000	$100–300	$150–400	$200–500	$300–800
Transesophageal echo (TEE)	$1,500–4,000	$300–800	$400–1,000	$500–1,200	$800–1,500
Cardiac MRI	$2,000–5,000	$500–1,200	$700–1,500	$900–2,000	$1,200–2,500
Cardiac catheterization	$5,000–15,000	$1,000–3,000	$1,500–4,000	$2,000–5,000	$3,000–7,000
ASD device closure	$15,000–35,000	$4,000–10,000	$6,000–14,000	$8,000–16,000	$12,000–25,000
ASD surgical closure	$30,000–70,000	$6,000–15,000	$8,000–18,000	$10,000–22,000	$15,000–30,000
Annual follow-up visit	$300–1,000	$80–200	$120–300	$150–400	$250–500

All figures are approximate and vary widely by hospital and patient. Medical tourism to JCI-accredited centers in India, Turkey, or Thailand commonly saves 50–90% versus US prices, often with all-inclusive packages—though travel, accommodation, and follow-up should be factored in. Insurance coverage varies and often needs pre-authorization, and quality should weigh more than price alone. See our hospitals and destinations pages.

60. Factors Affecting Treatment Cost

Cost depends on patient factors (age, size, comorbidities) and defect characteristics—secundum defects amenable to a device are generally cheaper than primum or sinus venosus defects needing surgery, and multiple defects or associated anomalies (valve repair, vein rerouting) add cost. The approach (device versus surgery, and any concomitant procedures), facility and provider factors (hospital type, location, accreditation, volume, specialist experience), length of stay, and any complications all influence the total. For medical travelers, travel, accommodation, and lost wages add to the base price.

61. Choosing the Right Specialist

Match the specialist to your situation. Children need a pediatric cardiologist, with a pediatric interventional cardiologist for device closure or a pediatric cardiac surgeon for surgery. Adults are best served by an adult congenital heart disease (ACHD) specialist, an interventional cardiologist experienced in structural heart procedures, and, when surgery is needed, a cardiac surgeon who regularly performs congenital cases. Key criteria: board certification, high procedural volume, transparent outcomes data, and clear communication that welcomes questions and second opinions. Browse our doctors directory to start.

62. Choosing the Right Hospital or Treatment Centre

Hospital quality strongly affects outcomes. Look for accreditation—Joint Commission International (JCI) is the gold standard for international hospitals—and a dedicated congenital heart program with full-service cardiology, interventional cardiology, cardiac surgery, and a specialized cardiac ICU. Favor high-volume centers with board-certified specialists, and ask about outcomes: procedural success (over 95% for device, over 98% for surgery) and low mortality and complication rates. International patients should verify English-speaking staff, international coordinators, travel assistance, transparent pricing, and follow-up coordination. Our hospitals listings help you compare accredited centers.

63. Getting a Second Medical Opinion

A second opinion is worthwhile when significant surgery is recommended, the anatomy is complex, treatment approaches differ (device versus surgery), comorbidities or pregnancy complicate the decision, or you simply feel unsure. To make it productive, gather all records (echocardiograms, ECGs, catheterization reports, and actual images) and ask focused questions: Do you agree with the diagnosis and plan? What alternatives exist? A good second opinion offers confirmation, a possible alternative approach, or a clearer explanation. Your first physician should support the process and share records promptly; most insurers cover it.

64. Treatment Abroad and Medical-Travel Considerations

Popular destinations for affordable, high-quality ASD care include India, Turkey, and Thailand (typically 50–80% savings), Singapore (higher cost, excellent outcomes), and Mexico or Costa Rica for North Americans. Advantages include major savings at JCI-accredited hospitals with board-certified, often Western-trained specialists and short wait times. Challenges include language differences, continuity of care after you return, limited legal recourse, insurance that often will not cover foreign care, and the risks of long flights soon after a cardiac procedure. When choosing a center, verify JCI accreditation, physician credentials and volume, outcomes data, and international patient services, transfer records ahead, plan a 2–4 week stay, and—crucially—arrange local follow-up before departure. Our contact team can help coordinate.

65. Frequently Asked Questions

Q: Can atrial septal defects close on their own? A: Small secundum defects (<5 mm) often close spontaneously in early childhood—many by age 3–4. Moderate-to-large defects (≥5 mm) rarely close and usually require intervention.

Q: Will my child “outgrow” an ASD? A: A significant ASD does not disappear as a child grows. Waiting for a child to outgrow one is not appropriate—timely closure before complications is the standard of care.

Q: How do I know if my ASD needs closing? A: Closure is generally recommended for a significant shunt (Qp:Qs >1.5:1), right heart enlargement, symptoms, or complications. Small defects with a normal-sized right heart may be safely observed.

Q: Device closure or surgery—which is better? A: Neither is universally better. Device closure suits most secundum defects, with faster recovery and no chest scar; surgery is required for primum and sinus venosus defects, very large defects, or those needing associated repairs.

Q: Can an ASD cause a stroke? A: Yes, though uncommonly—a venous clot can cross the defect (paradoxical embolism) and reach the brain. After a stroke or TIA with an ASD, closure is usually recommended.

Q: Can I play sports and have children after closure? A: Yes. After recovery, patients return to normal activity including competitive sport, and women who close a significant ASD before pregnancy typically have normal-risk pregnancies.

Q: Will I need blood thinners, and how long is the hospital stay? A: After device closure, most patients take aspirin for about 6 months and stay one night; surgery involves a 3–5 day stay and usually no long-term aspirin unless another indication exists.

66. Patient Stories and Treatment Experiences

These stories are representative composites and do not identify specific individuals.

Emma, 8 — United Kingdom. Emma’s 12 mm secundum ASD with right heart enlargement was found when a school physical detected a murmur. She had device closure at age 5, went home the next day, and was back at school within a week. Three years on, she swims competitively and her echocardiogram is normal. Her mother’s advice: “Don’t panic—children recover so quickly.”

Michael, 42 — Canada. Breathlessness during basketball, dismissed as being “out of shape,” led to an echocardiogram showing a large secundum ASD. He had device closure, stayed one night, returned to work within a week, and resumed basketball after six weeks with fully restored stamina. “The breathlessness I’d blamed on aging was completely reversible—don’t ignore symptoms.”

Priya, 28 — India. A murmur at a pregnancy checkup revealed a 15 mm secundum ASD with right heart enlargement, and doctors advised closing it before pregnancy. After device closure and a six-month wait, she delivered a healthy son and has had normal checkups since. “I’m so grateful it was found when it was—waiting could have been dangerous.”

67. Latest Research and Current Practice

Research continues to refine ASD care. Imaging advances include 3D echocardiography, more precise MRI shunt quantification, and intracardiac echocardiography (ICE) that can guide device closure without TEE or general anesthesia. Device technology is evolving toward bioresorbable occluders, lower-profile and recapturable designs, and lower-nickel materials. Minimally invasive surgery—robotic, thoracoscopic, and hybrid approaches—is expanding, and large adult CHD and device-durability registries track outcomes 20+ years after closure. Practice is guided by regularly updated ACC/AHA, ESC, and pediatric cardiology recommendations; some centers offer clinical-trial or registry participation—ask your cardiologist.

Ventricular Septal Defects — a “hole in the heart” between the lower chambers, with similar shunt physiology.
Patent Ductus Arteriosus — a persistent connection between the aorta and pulmonary artery.
Atrioventricular Septal Defect — a more complex defect involving both septa, related to primum ASD.
Tricuspid Valve Disease — leaky tricuspid valve secondary to right heart enlargement.
Disorders of Heart Rhythm — atrial fibrillation and flutter, common in adults with ASD.
Heart Failure — right heart failure and pulmonary hypertension from an untreated ASD.

Congenital Heart Procedures — surgical and catheter-based treatments for congenital defects, including ASD closure.
Minimally Invasive Cardiac LIS — less invasive surgical approaches for ASD repair.
Hybrid Cardiac Procedures — combined surgical and catheter-based techniques.
Electrophysiological Procedures — ablation and devices for associated arrhythmias.
Mitral Valve Procedures — for coexisting mitral valve disease.

70. Medical Glossary

Atrial septal defect (ASD) — a hole in the atrial septum allowing blood to shunt from the left atrium to the right atrium.

Echocardiography (echo) — ultrasound imaging of the heart; the primary diagnostic test for ASD.

Eisenmenger syndrome — a late complication in which severe pulmonary hypertension reverses the shunt to right-to-left, causing cyanosis.

Foramen ovale — a normal fetal opening between the atria that usually closes after birth; may persist as a patent foramen ovale (PFO).

Left-to-right shunt — abnormal flow from the left atrium to the right atrium through an ASD, overloading the right heart.

Paradoxical embolism — passage of a venous clot through the defect into the arterial circulation, potentially causing stroke.

Qp:Qs ratio — the ratio of pulmonary to systemic blood flow; above 1.5:1 indicates a significant shunt.

Right heart enlargement — dilation of the right atrium and ventricle from chronic volume overload; its reversal is a key goal of closure.

Secundum ASD — the most common type, in the central septum; most amenable to device closure.

Transesophageal echocardiography (TEE) — echo via an esophageal probe for superior septal views; essential for device planning.

71. Medical Review, Editorial Policy and Last Updated Date

Last updated: 11 July 2026

Medical Review Policy: This content is reviewed and updated regularly by cardiac specialists for accuracy and alignment with current practice, reflecting consensus guidelines from major cardiology societies (ACC/AHA, ESC, American Academy of Pediatrics) and standard cardiology textbooks.

Editorial Policy: Content is written for patient and family education; treatment options reflect evidence-based guidelines; no specific product, device, or hospital is endorsed; cost estimates are approximate; and individual decisions require consultation with qualified specialists.

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician with any questions about a medical condition, and never disregard or delay professional advice because of something read here. If you think you may have a medical emergency, call your doctor or emergency services immediately.

72. Clinical Guidelines and Medical References

This content is consistent with current clinical practice guidelines from leading bodies:

ACC/AHA Guidelines for the Management of Adults with Congenital Heart Disease
ACC/AHA guidance on congenital heart disease in children and adolescents
European Society of Cardiology (ESC) Guidelines for Grown-up Congenital Heart Disease
ESC Guidelines for the Management of Atrial Fibrillation
American Academy of Pediatrics guidance on pediatric congenital heart disease

Standard textbook references include Moss & Adams’ Heart Disease in Infants, Children, and Adolescents and Braunwald’s Heart Disease, along with peer-reviewed device-closure studies and adult congenital heart disease (ACHD) registry data.

73. Book an Appointment or Request a Second Opinion

Take control of your heart health today. If you or your child has been diagnosed with an atrial septal defect—or you have symptoms that concern you—don’t wait. Early intervention prevents complications and allows a completely normal life after treatment.

We can help you connect with top cardiac specialists and JCI-accredited hospitals worldwide, explore your options (device closure, surgical repair, or observation), obtain an expert second opinion, and arrange affordable, high-quality care abroad with help on records and travel.

Get started:

Book now: /contact/
Contact us: /contact/
Email: info@bestheartsurgery.com

ASDs are highly treatable: with modern cardiac care, most children and adults return to full, active lives with a normal life expectancy after successful closure.

Disclaimer: This service provides information and connection to healthcare providers; it does not provide medical advice or diagnosis. Always consult qualified healthcare professionals for medical decisions.

Atrial Septal Defects